UK Health Security Agency, 30 October 2024 The UK Health Security Agency (UKHSA) has detected a single confirmed human case of Clade Ib mpox. The risk to the UK population remains low. This is the first detection of this Clade of mpox in the UK. It is different from mpox Clade II that has been circulating at low levels in the UK since 2022, primarily among gay, bisexual and other men-who-have-sex...
HIV notifications among people from CALD backgrounds in Australia
Improving our understanding of HIV notifications among people from Culturally and Linguistically Diverse backgrounds in Australia By Ela Naruka, Research Officer, Kirby Institute, October 23, 2024 Over the past decade (2014-2023), there has been a 21.5% increase in HIV notifications among people from CALD backgrounds. In 2014, there were 306 notifications (28% of total notifications), which rose...
HIV diagnoses trending down in Australia despite 2023 increase
Kirby Institute, UNSW |Media release | Published on 04 Sep 2024 Over the last decade, HIV diagnoses in Australia have continued to follow a downward trend, according to new data released today by the Kirby Institute at UNSW Sydney. While there were 722 new HIV diagnoses reported nationally in 2023 – up from 553 in 2022 – the researchers still reported a lower number of annual cases compared to...
Women ‘bombarded’ by untested claims about menopause products, Senate inquiry hears
ABC, 8.8.2024 Ads for products promising to address the symptoms of menopause and perimenopause are flooding social media, creating a “shameful marketing war zone” in which many claims are left unsubstantiated, a Senate inquiry has heard. Ads for products promising to address the symptoms of menopause and perimenopause are flooding social media, creating a “shameful marketing...
Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...
Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia
Shih, Sophy & Cheng, Qinglu & Carson, Joanne & Valerio, Heather & Sheehan, Yumi & Gray, Richard & Cunningham, Evan & Kwon, Jisoo & Lloyd, Andrew & Dore, Gregory & Wiseman, Virginia & Grebely, Jason. (2023). Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost...